Automated blood pressure monitoring for the assessment of antihypertensive treatment. 1988

M A Weber
Hypertension Center, Veterans Administration Medical Center, Long Beach, California 90822.

Whole-day automated monitoring with small portable devices allows the circadian pattern of blood pressure to be assessed conveniently in individual patients. Measurements provided by this technique appear to be more reproducible and physiologically relevant than conventional office readings. Ambulatory monitoring can enhance the evaluation of antihypertensive therapy, especially in clinical trials, in 3 ways. First, it can facilitate the diagnosis of hypertension and avoid potentially inappropriate treatment in patients whose hypertension is erroneously diagnosed by office measurements. Moreover, the monitoring technique appears to prevent placebo responses in therapeutic studies. Second, whole-day monitoring allows clear quantification of treatment effects. Because the standard deviations of treatment-induced blood pressure differences are lower with this method than with conventional readings, valid statistical evaluation of antihypertensive effects can be performed with far fewer patients. Finally, duration of action of drugs can be measured. By dividing the day into sequential periods (typically 12 two-hour periods), it is possible to determine statistical differences between baseline and treatment blood pressure values throughout the dosing intervals of the drugs being tested. This method may be more sensitive than the traditional "peak and trough" approach for assessing duration of action; it is not influenced by unsuspected discrepancies between the pharmacokinetic and pharmacodynamic properties of drugs, and can also provide information on nighttime effects. Thus, automated whole-day blood pressure monitoring appears to be a powerful tool for the evaluation of antihypertensive therapy.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D001795 Blood Pressure Determination Techniques used for measuring BLOOD PRESSURE. Blood Pressure Determinations,Determination, Blood Pressure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M A Weber
June 1991, Clinical and investigative medicine. Medecine clinique et experimentale,
M A Weber
January 1986, Journal of cardiovascular pharmacology,
M A Weber
December 1992, European heart journal,
M A Weber
December 1992, Journal of human hypertension,
M A Weber
December 1989, The American journal of medicine,
M A Weber
March 1997, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
Copied contents to your clipboard!